1. Based on DCF valuation techniques, what range of values is reasonable for Genentech as a stand-alone...
Fantastic news! We've Found the answer you've been seeking!
Question:
1.Based on DCF valuation techniques, what range of values is reasonable for Genentech as a stand-alone company in June 2008?Please exclude synergies from your valuation and use a 9% weighted average cost of capital.You can assume that as of the end of June 2008, Genentech held approximately $7 billion in cash, which included investments and securities that were not needed in its daily operations.(Exhibit 10 is a good starting point for this analysis)
Related Book For
Posted Date: